The rapid development of the COVID-19 vaccine has created a dramatic shift in the way the public and life sciences organizations view the manufacturing of pharmaceuticals. In a recent Q&A with Pharma Manufacturing, Nathan Pettus, president of Emerson’s process...
We have witnessed an incredible change the last few years in how life sciences manufacturers deliver treatments. Today’s focus is on fast results, and that means products patients rely on cannot sit on shelves for weeks or months waiting on quality validation. In a...
In the chemical industry, manufacturers often need to change operations or accommodate new products to meet customer demand. However, the extensive integration efforts required to connect manufacturing equipment and automation systems often complicate engineering,...
Modular facilities are a key enabler of speed to market in life sciences. As organizations try to bring new therapies to market faster, those therapies require a wide variety of equipment—many of which are new to the process. These new machines must not only work...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.